Basal cell carcinoma, including avohilmo

PheWeb

C3_BASAL_CELL_CARCINOMA_INCLAVO

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Primary healthcare outpatient ICD-10: C44.01, C44.11, C44.21, C44.31, C44.41, C44.51, C44.61, C44.71, C44.81, C44.91

2510

Check pre-conditions, main-only, mode, ICD version None

2510

Check minimum number of events None

2510

Include endpoints

C3_BASAL_CELL_CARCINOMA

14914

C3_BASAL_CELL_CARCINOMA_INCLAVO

Extra metadata

Level in the ICD hierarchy C

First used in FinnGen datafreeze DF7

Similar endpoints

↥

List of similar endpoints to Basal cell carcinoma, including avohilmo based on the number of shared cases.

Broader endpoints:

None

Narrower endpoints:

Basal cell carcinoma

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	14492	6941	7551
Unadjusted prevalence (%)	4.70	4.00	5.59
Mean age at first event (years)	66.07	64.49	67.52

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.02	1.22 [1.01, 1.47]	3.6e-2	2077
15 years	0.00	0.76 [0.65, 0.90]	1.1e-3	990
5 years	0.00	1.49 [1.29, 1.71]	2.4e-8	645
1 year	0.00	2.07 [1.70, 2.51]	4.6e-13	176

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_BASAL_CELL_CARCINOMA_INCLAVO – Basal cell carcinoma, including avohilmo
GWS hits:

Survival analyses between endpoints

↥

Plot

before Basal cell carcinoma, including avohilmo
after Basal cell carcinoma, including avohilmo

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Basal cell carcinoma, including avohilmo

↥